Altimmune (ALT) Current Taxes (2016 - 2022)
Altimmune's (ALT) quarterly Current Taxes came in at $1.2 million in Q3 2022, down 62.98% on a QoQ basis from $3.2 million in Q4 2016.
Altimmune (ALT) Current Taxes (2016 - 2022) Analysis & Trends
Altimmune (ALT) has 2 years of Current Taxes data on file, last reported at $1.2 million in Q3 2022.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $1.2 million in Q3 2022; TTM through Sep 2022 was $1.2 million, a N/A change from a year earlier, with the FY2016 full-year figure at $3.2 million, changed N/A from the prior year.
- Current Taxes for Q3 2022 stood at $1.2 million, down from $3.2 million in the prior quarter.
- Over the last five years, Current Taxes for ALT reached as high as $1.2 million in Q3 2022 and fell as low as $1.2 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.17 Mn |
| Dec 31, 2016 | 3.16 Mn |